Health CanadaGeneral Alert
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
Published: September 18, 2018Recall ID: 58284Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 58284 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/tecentriqr-atezolizumab-risk-immune-related-nephritis |
| Issue | Product safety |
| Title | TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2018-09-18 |
| Organization | Marketed health products |